Papers
2
Total Citations
18
H-Index
2
About
Dr. Mario Giuffrida is a leading figure in the advancement of minimally invasive hepatobiliary and pancreatic surgery, with a particular focus on the surgical management of hepatocellular carcinoma (HCC). His work is distinguished by a dual commitment to both pioneering surgical techniques and the systematic, large-scale dissemination of best practices. Dr. Giuffrida’s major contributions include landmark comparative studies that rigorously evaluate the safety and oncologic efficacy of robotic versus laparoscopic liver resections. His multicentric propensity-score matched analysis of 647 patients, published in 2025, provides critical evidence on surgical and oncologic outcomes, helping to define the role of robotic surgery in HCC treatment. Beyond individual studies, he has been instrumental in the "I Go MILS" registry, a decade-long Italian initiative that serves as a vital tool for characterization, networking, and the dissemination of mini-invasive liver surgery standards. With his most-cited work accumulating over a dozen citations in a short timeframe, Dr. Giuffrida is actively shaping the future of surgical oncology, bridging the gap between innovative technology and reproducible, patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1
- 2